Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr. MartensDOCMF 55 Capex-to-Operating-Cash-Flow is 0.04 as of Mar. 2026, which is 76% below its 10-year median of 0.17. GuruFocus rates DOCMF with a GF Score™ of 55/100 and a GF Value™ of $0.97 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 488 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks better than 85.66% on this metric.
Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.
Dr. Martens (OTCPK:DOCMF) Capex-to-Operating-Cash-Flow Explanation
Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.
Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.
Dr. Martens Capex-to-Operating-Cash-Flow Related Terms
Dr. Martens Capex-to-Operating-Cash-Flow Historical Data
* Premium members only.
The historical data trend for Dr. Martens's Capex-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOCMF vs NKE, DECK, ONON: Capex-to-Operating-Cash-Flow Comparison
For the Footwear & Accessories subindustry, Dr. Martens's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens Capex-to-Operating-Cash-Flow vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Capex-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Dr. Martens's Capex-to-Operating-Cash-Flow falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Cash-Flow of 0.04 mean?
Dr. Martens (DOCMF) has a Capex-to-Operating-Cash-Flow of 0.04 as of Mar. 2026. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Dr. Martens and its competitors. This is 76% below median its historical median of 0.17. Over the past decade, Dr. Martens' Capex-to-Operating-Cash-Flow has ranged from 0.08 to 0.71. According to the industry distribution chart, Dr. Martens ranks #70 out of 488 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 14.3%.
Is Dr. Martens' Capex-to-Operating-Cash-Flow too high?
Dr. Martens' current Capex-to-Operating-Cash-Flow of 0.04 is 76% below median its 10-year median of 0.17. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 0.71. The Manufacturing - Apparel & Accessories industry median Capex-to-Operating-Cash-Flow is 0.31. Dr. Martens' value of 0.04 is 87.1% below this industry median. Based on the distribution chart, Dr. Martens ranks #70 out of 488 companies in the Manufacturing - Apparel & Accessories industry, which is in the top quartile — a strong position relative to peers. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Capex-to-Operating-Cash-Flow compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #70 out of 488 companies for Capex-to-Operating-Cash-Flow. This places Dr. Martens in the top 14% of its industry — outperforming the majority of peers. The industry median Capex-to-Operating-Cash-Flow is 0.31. Dr. Martens' value of 0.04 is 87.1% below this benchmark. Historically, Dr. Martens' own Capex-to-Operating-Cash-Flow has ranged from 0.08 to 0.71 over the past decade. While the company's 10-year median is 0.17 vs. the industry median of 0.31, Dr. Martens has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Cash-Flow for a Manufacturing - Apparel & Accessories company?
The median Capex-to-Operating-Cash-Flow among Manufacturing - Apparel & Accessories companies is 0.31, based on 488 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Cash-Flow significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Cash-Flow should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current Capex-to-Operating-Cash-Flow of 0.04 is 87.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Cash-Flow mean?
A high Capex-to-Operating-Cash-Flow can signal that a stock is expensive relative to its fundamentals. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Capex-to-Operating-Cash-Flow is 0.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current Capex-to-Operating-Cash-Flow is 0.04, which is 76% below median its own 10-year median of 0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.97, compared to a current price of $1.20 — trading 23.7% above its estimated fair value. The current Capex-to-Operating-Cash-Flow is 0.04, which is 76% below median its 10-year median of 0.17 and 87.1% below the Manufacturing - Apparel & Accessories industry median of 0.31. Dr. Martens' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Cash-Flow calculated?
Capex-to-Operating-Cash-Flow is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current Capex-to-Operating-Cash-Flow is 0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DOCMF) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued.
The current stock price of $1.20 is trading 23.7% above its estimated GF Value™ of $0.97.
GuruFocus considers Dr. Martens to be Modestly Overvalued.
Key valuation signals for DOCMF:
Capex-to-Operating-Cash-Flow: 0.04 (76% below median its 10-year median of 0.17)
GF Value™: $0.97 vs. price of $1.20 (23.7% above fair value)
Industry Position: 87.1% below the Manufacturing - Apparel & Accessories median (#70 of 488)
No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score
Get the complete analysis for DOCMF
Capex-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCMF has been successfully added to your 
